Author details

Full Name

Zhen Zhang

Affiliation

ORCID

Career Start Year

1998

Papers

118

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37357306	VCAM-1 complements CA-125 in detecting recurrent ovarian cancer.	Clin Proteomics	2023
36765916	Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection.	Cancers (Basel)	2023
37461566	ABDS: tool suite for analyzing biologically diverse samples.	bioRxiv	2023
37186065	Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.		2023
35759857	ALK-fusion-positive secondary ameloblastic carcinoma reached complete response after using alectinib.	Oral Oncology	2022
34944713	Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.	Biomedicines	2021
33704733	Detection of Uveal Melanoma by Multiplex Immunoassays of Serum Biomarkers.	Methods Mol Biol	2021
33995654	A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.	Theranostics	2021
33715225	Novel mutations in the Myo5a gene cause a dilute coat color phenotype in mice.	FASEB Journal	2021
33417831	Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.	Cancer Cell	2021
35141146	One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer.	Frontiers in Oncology	2021
32954372	Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.	Cell Rep Med	2020
31923397	Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.	Cell	2020
33262351	Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.	Nat Commun	2020
33204318	Urinary glycoproteins associated with aggressive prostate cancer.	Theranostics	2020
32529193	Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.	Cell Rep Med	2020
30996714	Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA.	Clin Proteomics	2019
31675502	Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.	Cell	2019
31570013	Adnexal mass risk assessment: a multivariate index assay for malignancy risk stratification.	Future Oncology	2019
31702040	Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism.	Molecular Medicine Reports	2019
30333219	Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.	Cancer Epidemiol Biomarkers Prev	2019
30523211	Proteome-wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors.	Mol Cell Proteomics	2019
30867659	A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma.	Clin Proteomics	2019
29988108	Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry.	Nat Protoc	2018
27836980	Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.	Mol Cell Proteomics	2017
29124938	Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.	J Proteome Res	2017
26571101	Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides.	Nat Biotechnol	2016
26970494	Validation of a second-generation multivariate index assay forÂ malignancy risk of adnexal masses.	Am J Obstet Gynecol	2016
26739359	Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues.	Sci Rep	2016
27372738	Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.	Cell	2016
26867747	Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays.	Methods Mol Biol	2016
26719571	Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.	Clin Chem	2016
27312948	Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures.	J Proteome Res	2016
27206285	Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.	Int J Gynecol Cancer	2016
26653538	Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.	J Proteome Res	2016
26307160	Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?	J Urol	2016
26631509	An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.	Mol Cell Proteomics	2016
26578544	CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling.	Circulation: Cardiovascular Genetics	2016
25141849	Glycoproteins identified from heart failure and treatment models.	Proteomics	2015
25553114	Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers.	Theranostics	2015
25283129	Tissue proteomics using chemical immobilization and mass spectrometry.	Anal Biochem	2015
25781169	Overexpression of periostin in stroma positively associated with aggressive prostate cancer.	PLoS ONE	2015
25273109	KDDN: an open-source Cytoscape app for constructing differential dependency networks with significant rewiring.		2015
26096845	Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.	Cancer Cell	2015
26652794	MRMPlus: an open source quality control and assessment tool for SRM/MRM assay development.	BMC Bioinformatics	2015
26356563	Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.	Oncotarget	2015
26350498	BACOM2.0 facilitates absolute normalization and quantification of somatic copy number alterations in heterogeneous tumor.	Sci Rep	2015
26043260	Correction: Overexpression of periostin in stroma positively associated with aggressive prostate cancer.	PLoS ONE	2015
25212756	UNDO: a Bioconductor R package for unsupervised deconvolution of mixed gene expressions in tumor samples.	Bioinformatics	2015
25055984	Knowledge-fused differential dependency network models for detecting significant rewiring in biological networks.	BMC Systems Biology	2014